Header Logo

Connection

BRADY MOFFETT to Infant

Back to Details
This is a "connection" page, showing publications BRADY MOFFETT has written about Infant.
BRADY MOFFETT
Connection Strength
1.964
Infant
  1. Antibiotic Utilization and Efficacy Associated With Treating Pediatric Urinary Tract Infections in Texas Medicaid Patients in the First Year of Life. Pediatr Infect Dis J. 2021 11 01; 40(11):993-996.
    View in: PubMed
    Score: 0.063
  2. Antipyretic Efficacy of Acetaminophen and Ibuprofen in Critically Ill Pediatric Patients. Pediatr Crit Care Med. 2019 08; 20(8):e386-e393.
    View in: PubMed
    Score: 0.054
  3. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy. Eur J Clin Pharmacol. 2019 Aug; 75(8):1089-1097.
    View in: PubMed
    Score: 0.052
  4. Vancomycin associated acute kidney injury in pediatric patients. PLoS One. 2018; 13(10):e0202439.
    View in: PubMed
    Score: 0.051
  5. Population Pharmacokinetic Analysis of Gentamicin in Pediatric Extracorporeal Membrane Oxygenation. Ther Drug Monit. 2018 10; 40(5):581-588.
    View in: PubMed
    Score: 0.051
  6. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med. 2018 10; 19(10):973-980.
    View in: PubMed
    Score: 0.051
  7. Fosphenytoin Population Pharmacokinetics in the Acutely Ill Pediatric Population. Pediatr Crit Care Med. 2018 08; 19(8):748-754.
    View in: PubMed
    Score: 0.050
  8. Phenobarbital population pharmacokinetics across the pediatric age spectrum. Epilepsia. 2018 07; 59(7):1327-1333.
    View in: PubMed
    Score: 0.049
  9. Increased Fracture Risk with Furosemide Use in Children with Congenital Heart Disease. J Pediatr. 2018 08; 199:92-98.e10.
    View in: PubMed
    Score: 0.049
  10. Enoxaparin Population Pharmacokinetics in the First Year of Life. Ther Drug Monit. 2017 12; 39(6):632-639.
    View in: PubMed
    Score: 0.048
  11. Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
    View in: PubMed
    Score: 0.047
  12. Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
    View in: PubMed
    Score: 0.047
  13. Spironolactone effect on potassium supplementation in paediatric cardiac intensive care patients. J Clin Pharm Ther. 2017 Aug; 42(4):433-437.
    View in: PubMed
    Score: 0.046
  14. Efficacy of sequential nephron blockade with intravenous chlorothiazide to promote diuresis in cardiac intensive care infants. Cardiol Young. 2017 Aug; 27(6):1104-1109.
    View in: PubMed
    Score: 0.044
  15. Readmissions for Heart Failure in Children. J Pediatr. 2016 10; 177:153-158.e3.
    View in: PubMed
    Score: 0.043
  16. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate. Pediatr Nephrol. 2016 11; 31(11):2113-7.
    View in: PubMed
    Score: 0.043
  17. Variability in Treatment of Post-coarctectomy Hypertension: A Multicenter Study. Pediatr Cardiol. 2016 Apr; 37(4):772-7.
    View in: PubMed
    Score: 0.042
  18. Serum digoxin concentrations and clinical signs and symptoms of digoxin toxicity in the paediatric population. Cardiol Young. 2016 Mar; 26(3):493-8.
    View in: PubMed
    Score: 0.040
  19. Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database. Cardiol Young. 2015 Aug; 25(6):1080-5.
    View in: PubMed
    Score: 0.038
  20. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database. Pediatr Cardiol. 2015 Feb; 36(2):374-8.
    View in: PubMed
    Score: 0.038
  21. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Arch Pathol Lab Med. 2014 Sep; 138(9):1229-32.
    View in: PubMed
    Score: 0.038
  22. Dexmedetomidine utilisation and outcomes of children with trisomy 21 undergoing congenital heart disease surgery. Cardiol Young. 2015 Jun; 25(5):958-62.
    View in: PubMed
    Score: 0.038
  23. Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015 Jan; 36(1):146-50.
    View in: PubMed
    Score: 0.038
  24. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients. Congenit Heart Dis. 2015 Jan-Feb; 10(1):E6-10.
    View in: PubMed
    Score: 0.038
  25. National prescribing trends for heart failure medications in children. Congenit Heart Dis. 2015 Jan-Feb; 10(1):78-85.
    View in: PubMed
    Score: 0.037
  26. Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study. ASAIO J. 2014 Mar-Apr; 60(2):211-5.
    View in: PubMed
    Score: 0.037
  27. Amiodarone monitoring practices in pediatric hospitals in the United States. Pediatr Cardiol. 2013; 34(8):1762-6.
    View in: PubMed
    Score: 0.035
  28. Analysis of vancomycin therapeutic drug monitoring trends at pediatric hospitals. Pediatr Infect Dis J. 2013 Jan; 32(1):32-5.
    View in: PubMed
    Score: 0.034
  29. Response to intravenous potassium chloride supplementation in pediatric cardiac intensive care patients. Pediatr Cardiol. 2013 Apr; 34(4):887-92.
    View in: PubMed
    Score: 0.034
  30. Ketorolac-associated renal morbidity: risk factors in cardiac surgical infants. Cardiol Young. 2013 Oct; 23(5):752-4.
    View in: PubMed
    Score: 0.033
  31. Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients. Pediatr Blood Cancer. 2012 Jun; 58(6):941-4.
    View in: PubMed
    Score: 0.031
  32. Risk factors for postoperative acute kidney injury in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. Pediatr Crit Care Med. 2011 Sep; 12(5):555-9.
    View in: PubMed
    Score: 0.031
  33. Impact of pharmacotherapy on interstage outcomes in single ventricle infants. Congenit Heart Dis. 2011 Jul-Aug; 6(4):286-93.
    View in: PubMed
    Score: 0.031
  34. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol. 2011 Oct; 32(7):896-903.
    View in: PubMed
    Score: 0.030
  35. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011 Apr; 6(4):856-63.
    View in: PubMed
    Score: 0.030
  36. Gentamicin dosing for pediatric patients with congenital heart disease. Pediatr Cardiol. 2010 Aug; 31(6):761-5.
    View in: PubMed
    Score: 0.028
  37. Sodium-nitroprusside-induced cyanide toxicity in pediatric patients. Expert Opin Drug Saf. 2009 Sep; 8(5):599-602.
    View in: PubMed
    Score: 0.027
  38. Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann Pharmacother. 2008 Nov; 42(11):1600-4.
    View in: PubMed
    Score: 0.025
  39. Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review. Pediatr Crit Care Med. 2008 Jul; 9(4):403-6.
    View in: PubMed
    Score: 0.025
  40. Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation. Pediatr Cardiol. 2008 Jul; 29(4):744-8.
    View in: PubMed
    Score: 0.024
  41. Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease. Am J Ther. 2007 Jul-Aug; 14(4):331-5.
    View in: PubMed
    Score: 0.023
  42. Safety of ketorolac in neonates and infants after cardiac surgery. Paediatr Anaesth. 2006 Apr; 16(4):424-8.
    View in: PubMed
    Score: 0.021
  43. A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin Therapy. Pharmacotherapy. 2025 Aug; 45(8):504-511.
    View in: PubMed
    Score: 0.020
  44. Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients. Crit Care Explor. 2024 Oct 01; 6(10):e1159.
    View in: PubMed
    Score: 0.019
  45. Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic Modeling. Antimicrob Agents Chemother. 2022 04 19; 66(4):e0189921.
    View in: PubMed
    Score: 0.016
  46. Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real-World Data: A Pharmacokinetic-Pharmacodynamic Modeling Approach. J Clin Pharmacol. 2022 06; 62(6):733-746.
    View in: PubMed
    Score: 0.016
  47. Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. J Clin Pharmacol. 2021 06; 61 Suppl 1:S125-S132.
    View in: PubMed
    Score: 0.015
  48. Hospital outcomes for pediatric heart transplant recipients undergoing tracheostomy: A multi-institutional analysis. Pediatr Transplant. 2021 May; 25(3):e13904.
    View in: PubMed
    Score: 0.015
  49. Extracorporeal Membrane Oxygenation Mortality in High-Risk Populations: An Analysis of the Pediatric Health Information System Database. ASAIO J. 2020 03; 66(3):327-331.
    View in: PubMed
    Score: 0.014
  50. Characteristics and outcomes of children with congenital heart disease needing diaphragm plication. Cardiol Young. 2020 Jan; 30(1):62-65.
    View in: PubMed
    Score: 0.014
  51. Characteristics and Outcomes of Pediatric Patients Supported With Ventricular Assist Device-A Multi-Institutional Analysis. Pediatr Crit Care Med. 2019 08; 20(8):744-752.
    View in: PubMed
    Score: 0.013
  52. Thoracic Aortic, Aortic Valve, and Mitral Valve Surgery in Pediatric and Young Adult Patients With Marfan Syndrome: Characteristics and Outcomes. Semin Thorac Cardiovasc Surg. 2019; 31(4):818-825.
    View in: PubMed
    Score: 0.013
  53. Hypotensive Response to IV Acetaminophen in Pediatric Cardiac Patients. Pediatr Crit Care Med. 2019 06; 20(6):527-533.
    View in: PubMed
    Score: 0.013
  54. Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson. Pediatr Cardiol. 2018 Aug; 39(6):1249-1257.
    View in: PubMed
    Score: 0.012
  55. Epinephrine syringe exchange events in a paediatric cardiovascular ICU: analysing the storm. Cardiol Young. 2018 Mar; 28(3):409-415.
    View in: PubMed
    Score: 0.012
  56. Enhancement of diuresis with metolazone in infant paediatric cardiac intensive care patients. Cardiol Young. 2018 Jan; 28(1):27-31.
    View in: PubMed
    Score: 0.012
  57. Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis. J Pediatr. 2015 Sep; 167(3):645-9.
    View in: PubMed
    Score: 0.010
  58. Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. Pediatr Cardiol. 2015 Oct; 36(7):1465-9.
    View in: PubMed
    Score: 0.010
  59. Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. J Pediatr. 2015 Jan; 166(1):115-8.
    View in: PubMed
    Score: 0.010
  60. Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients. Pediatr Cardiol. 2014 Jun; 35(5):767-70.
    View in: PubMed
    Score: 0.009
  61. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):678-86.e1; discussion 685-6.
    View in: PubMed
    Score: 0.009
  62. Impact of postoperative nutrition on weight gain in infants with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2014 Apr; 147(4):1319-25.
    View in: PubMed
    Score: 0.009
  63. Infectious complications and outcomes in children supported with left ventricular assist devices. J Heart Lung Transplant. 2013 May; 32(5):518-24.
    View in: PubMed
    Score: 0.009
  64. Warfarin anticoagulation after congenital heart surgery at a large children's hospital. Pediatr Cardiol. 2012 Dec; 33(8):1377-82.
    View in: PubMed
    Score: 0.008
  65. Perioperative atrial tachycardia is associated with increased mortality in infants undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2012 Aug; 144(2):396-401.
    View in: PubMed
    Score: 0.008
  66. Impact of dexmedetomidine on early extubation in pediatric cardiac surgical patients. Intensive Care Med. 2011 Apr; 37(4):686-90.
    View in: PubMed
    Score: 0.007
  67. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med. 2011 Jan; 12(1):28-32.
    View in: PubMed
    Score: 0.007
  68. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol. 2010 Aug 10; 56(7):582-92.
    View in: PubMed
    Score: 0.007
  69. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant. 2011 Jan; 26(1):144-50.
    View in: PubMed
    Score: 0.007
  70. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis. Pharmacotherapy. 2010 Mar; 30(3):248-53.
    View in: PubMed
    Score: 0.007
  71. Safety and efficacy of nesiritide in pediatric heart failure. J Card Fail. 2007 Sep; 13(7):541-8.
    View in: PubMed
    Score: 0.006
  72. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol. 2006 Jul-Aug; 27(4):402-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.